|
Re: I asked IR...
|
6
|
Resverlogix Corp.
|
Oct 24, 2019 05:14PM
|
|
Re: Apabetalone......a Calculated Risk
|
6
|
Resverlogix Corp.
|
Apr 09, 2019 08:10AM
|
|
Re: Article on NASH Liver Disease
|
6
|
Resverlogix Corp.
|
Aug 18, 2019 02:27AM
|
|
Re: Patience
|
6
|
Resverlogix Corp.
|
Jan 18, 2022 08:28AM
|
|
Re: So what's the Bottom Line?
|
6
|
Resverlogix Corp.
|
Nov 18, 2019 09:14AM
|
|
Re: Warrants conversion!
|
6
|
Resverlogix Corp.
|
Nov 27, 2019 05:29AM
|
|
DSMB
|
6
|
Resverlogix Corp.
|
Feb 21, 2019 06:08PM
|
|
Re: Question
|
6
|
Resverlogix Corp.
|
Feb 24, 2021 07:01PM
|
|
Perspective
|
6
|
Resverlogix Corp.
|
Dec 07, 2019 03:40AM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
6
|
Resverlogix Corp.
|
Jun 22, 2020 09:50AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
6
|
Resverlogix Corp.
|
Jun 14, 2020 02:25AM
|
|
Re: Eversana ValuationCaseStudy
|
6
|
Resverlogix Corp.
|
Jan 07, 2022 04:36PM
|
|
Just a thought……
|
7
|
Resverlogix Corp.
|
Feb 21, 2022 09:52PM
|
|
Re: Comments on today's annual update
|
7
|
Resverlogix Corp.
|
Jun 23, 2021 09:42AM
|
|
Re: Covid still alive
|
7
|
Resverlogix Corp.
|
Mar 13, 2022 07:20PM
|
|
Re: Deal Closing?
|
7
|
Resverlogix Corp.
|
May 28, 2019 06:52PM
|
|
Re: Reading (parsing, fantasizing) the tea leaves
|
7
|
Resverlogix Corp.
|
Jan 31, 2021 02:06AM
|
|
Re: Covid still alive
|
7
|
Resverlogix Corp.
|
Mar 14, 2022 02:13AM
|
|
Re: RVX rises above 200-day moving average
|
7
|
Resverlogix Corp.
|
Sep 21, 2020 05:39PM
|
|
Re: Potential Suitor
|
7
|
Resverlogix Corp.
|
Sep 12, 2020 07:11PM
|
